1.
2.
Folia Med (Plovdiv)
; 64(3): 422-429, 2022 Jun 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35856103
RESUMO
INTRODUCTION: Mycoplasmagenitalium is an established cause of sexually transmitted infections in men and women. Current guidelines recommend azithromycin and moxifloxacin as first- and second-line treatment, respectively. However, azithromycin treatment failure has been increasingly reported. The aim of this study was to determine the efficacy of azithromycin and alternative antibiotic regimens in a prospective cohort of M.genitalium-positive patients, and macrolide resistance mutations associated with azithromycin failure.